Neumora Therapeutics (NMRA) Accounts Payables (2022 - 2026)
Neumora Therapeutics (NMRA) posted Accounts Payables of $4.15 million for Q2 2026, up 543.9% from $644,000 a year earlier but down 18.0% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Accounts Payables (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics' Accounts Payables came in at $3.38 million, up 2.2% from FY2024.
- Annual Accounts Payables shows a three-year compound annual growth rate of -22.1% (FY2022 to FY2025).
- In prior years, Neumora Therapeutics' Accounts Payables was $3.31 million in FY2024 (+881.3%), $337,000 in FY2023 (-95.3%) and $7.15 million in FY2022.
- Quarterly Accounts Payables has run from a low of $337,000 in Q4 2023 to a high of $7.15 million in Q4 2022 over five years.
- On a year-over-year basis, Accounts Payables has increased in each of the last three quarters, with growth averaging 227.6% over the last eight quarters.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2024, with growth of 881.3%; the weakest was Q4 2023, with a decline of 95.3%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $5.06 million (Q1 2026), $3.38 million (Q4 2025) and $549,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Neumora Therapeutics | 129.65 Mn | 129.65 Mn | - | 4.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.15 Mn |
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 644,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 337,000.00 |
| Sep 30, 2023 | 2.23 Mn |
| Dec 31, 2022 | 7.15 Mn |
API Access
Neumora Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();